HEADER CYTOSOLIC PROTEIN 03-JUL-19 6S6W TITLE CRYSTAL STRUCTURE OF HUMAN ALDH1A3 IN COMPLEX WITH 2,6- TITLE 2 DIPHENYLIMIDAZO[1,2-A]PYRIDINE (COMPOUND GA11) AND NAD+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDEHYDE DEHYDROGENASE FAMILY 1 MEMBER A3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALDEHYDE DEHYDROGENASE 6,RETINALDEHYDE DEHYDROGENASE 3, COMPND 5 RALDH3; COMPND 6 EC: 1.2.1.36; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALDH1A3, ALDH6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS ALDH1A3 GA11 GLIOMA 2, 6-DIPHENYLIMIDAZO[1, 2-A]PYRIDINE KEYWDS 2 RETINALDEHYDE DEHYDROGENASE INHINITOR ALDHS, CYTOSOLIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.L.M.GELARDI,L.QUATTRINI,C.LAMOTTA,D.M.FERRARIS,S.GARAVAGLIA REVDAT 3 24-JAN-24 6S6W 1 LINK REVDAT 2 27-MAY-20 6S6W 1 JRNL REVDAT 1 22-APR-20 6S6W 0 JRNL AUTH L.QUATTRINI,E.L.M.GELARDI,V.COVIELLO,S.SARTINI,D.M.FERRARIS, JRNL AUTH 2 M.MORI,I.NAKANO,S.GARAVAGLIA,C.LA MOTTA JRNL TITL IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS ALDEHYDE DEHYDROGENASE JRNL TITL 2 INHIBITORS: NOVEL CHEMOTYPES TO TARGET GLIOBLASTOMA STEM JRNL TITL 3 CELLS. JRNL REF J.MED.CHEM. V. 63 4603 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32223240 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01910 REMARK 2 REMARK 2 RESOLUTION. 3.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 18877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 78.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6S6W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1292103200. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07227 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : RONTEC XFLASH X-RAY FLUORESCENCE REMARK 200 DETECTOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS OSX_64 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18877 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.250 REMARK 200 RESOLUTION RANGE LOW (A) : 48.017 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12800 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.78700 REMARK 200 R SYM FOR SHELL (I) : 0.78700 REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.2 REMARK 200 STARTING MODEL: 5FHZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4M NAMALONATE PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 40.77850 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.51850 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 40.77850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 79.51850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 23380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 61370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -105.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 81.55700 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 20 REMARK 465 PRO A 21 REMARK 465 ARG A 22 REMARK 465 GLY A 382 REMARK 465 GLY A 383 REMARK 465 GLU A 387 REMARK 465 ASP A 388 REMARK 465 LYS A 389 REMARK 465 GLY A 390 REMARK 465 LEU A 391 REMARK 465 PHE A 392 REMARK 465 ILE A 393 REMARK 465 LYS A 394 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 701 O HOH B 703 2.05 REMARK 500 O PHE A 330 OG SER A 334 2.06 REMARK 500 OD1 ASN B 53 OG SER B 55 2.07 REMARK 500 O TYR A 215 OG SER A 218 2.09 REMARK 500 O LEU A 368 OG SER A 371 2.11 REMARK 500 NH2 ARG A 109 OE2 GLU A 222 2.12 REMARK 500 O TYR B 215 OG SER B 218 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 226 C PRO A 227 N 0.155 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 109 CB - CA - C ANGL. DEV. = -13.3 DEGREES REMARK 500 CYS A 196 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 PRO A 227 C - N - CA ANGL. DEV. = 13.2 DEGREES REMARK 500 PRO A 227 C - N - CD ANGL. DEV. = -13.4 DEGREES REMARK 500 GLU B 375 N - CA - CB ANGL. DEV. = -11.3 DEGREES REMARK 500 GLU B 375 N - CA - C ANGL. DEV. = 16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 26 74.86 -115.40 REMARK 500 ARG A 57 106.98 -57.55 REMARK 500 ILE A 132 -72.83 -106.25 REMARK 500 THR A 158 -60.54 -128.18 REMARK 500 HIS A 168 76.15 -106.82 REMARK 500 CYS A 196 36.59 -84.28 REMARK 500 THR A 239 -61.85 -97.94 REMARK 500 SER A 272 -62.89 -109.84 REMARK 500 LEU A 274 26.04 49.68 REMARK 500 LEU A 281 -162.37 -102.89 REMARK 500 VAL A 306 -54.50 -137.87 REMARK 500 CYS A 313 143.37 -177.04 REMARK 500 ILE A 357 -61.61 -95.13 REMARK 500 ILE A 365 -60.89 -93.83 REMARK 500 ALA A 377 119.96 -167.74 REMARK 500 LEU A 439 -72.87 -125.62 REMARK 500 LYS A 481 -124.57 47.20 REMARK 500 SER A 483 1.45 -65.40 REMARK 500 THR B 32 38.51 -142.33 REMARK 500 ILE B 60 -63.05 -91.23 REMARK 500 GLN B 102 -14.92 81.41 REMARK 500 ASP B 110 37.88 -83.66 REMARK 500 THR B 158 -74.15 -134.37 REMARK 500 SER B 272 -63.88 -93.82 REMARK 500 ASN B 273 13.22 -143.15 REMARK 500 ASP B 292 47.38 -105.79 REMARK 500 PHE B 347 2.25 -67.07 REMARK 500 ASP B 358 -157.38 -138.70 REMARK 500 GLU B 380 -38.57 -133.60 REMARK 500 LEU B 391 58.59 -110.25 REMARK 500 GLU B 411 74.23 -107.02 REMARK 500 PHE B 413 -52.24 -125.06 REMARK 500 LYS B 423 -59.28 -128.64 REMARK 500 THR B 435 -168.21 -102.14 REMARK 500 GLU B 459 39.90 -93.37 REMARK 500 CYS B 467 167.83 179.49 REMARK 500 ALA B 470 74.99 -103.72 REMARK 500 LYS B 481 -124.60 49.15 REMARK 500 MET B 482 30.80 -91.20 REMARK 500 LEU B 489 18.67 80.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KXT A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAD B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide NAD A 601 and LYS B REMARK 800 47 DBREF 6S6W A 20 508 UNP P47895 AL1A3_HUMAN 20 508 DBREF 6S6W B 20 508 UNP P47895 AL1A3_HUMAN 20 508 SEQRES 1 A 489 LEU PRO ARG PRO ILE ARG ASN LEU GLU VAL LYS PHE THR SEQRES 2 A 489 LYS ILE PHE ILE ASN ASN GLU TRP HIS GLU SER LYS SER SEQRES 3 A 489 GLY LYS LYS PHE ALA THR CYS ASN PRO SER THR ARG GLU SEQRES 4 A 489 GLN ILE CYS GLU VAL GLU GLU GLY ASP LYS PRO ASP VAL SEQRES 5 A 489 ASP LYS ALA VAL GLU ALA ALA GLN VAL ALA PHE GLN ARG SEQRES 6 A 489 GLY SER PRO TRP ARG ARG LEU ASP ALA LEU SER ARG GLY SEQRES 7 A 489 ARG LEU LEU HIS GLN LEU ALA ASP LEU VAL GLU ARG ASP SEQRES 8 A 489 ARG ALA THR LEU ALA ALA LEU GLU THR MET ASP THR GLY SEQRES 9 A 489 LYS PRO PHE LEU HIS ALA PHE PHE ILE ASP LEU GLU GLY SEQRES 10 A 489 CYS ILE ARG THR LEU ARG TYR PHE ALA GLY TRP ALA ASP SEQRES 11 A 489 LYS ILE GLN GLY LYS THR ILE PRO THR ASP ASP ASN VAL SEQRES 12 A 489 VAL CYS PHE THR ARG HIS GLU PRO ILE GLY VAL CYS GLY SEQRES 13 A 489 ALA ILE THR PRO TRP ASN PHE PRO LEU LEU MET LEU VAL SEQRES 14 A 489 TRP LYS LEU ALA PRO ALA LEU CYS CYS GLY ASN THR MET SEQRES 15 A 489 VAL LEU LYS PRO ALA GLU GLN THR PRO LEU THR ALA LEU SEQRES 16 A 489 TYR LEU GLY SER LEU ILE LYS GLU ALA GLY PHE PRO PRO SEQRES 17 A 489 GLY VAL VAL ASN ILE VAL PRO GLY PHE GLY PRO THR VAL SEQRES 18 A 489 GLY ALA ALA ILE SER SER HIS PRO GLN ILE ASN LYS ILE SEQRES 19 A 489 ALA PHE THR GLY SER THR GLU VAL GLY LYS LEU VAL LYS SEQRES 20 A 489 GLU ALA ALA SER ARG SER ASN LEU LYS ARG VAL THR LEU SEQRES 21 A 489 GLU LEU GLY GLY LYS ASN PRO CYS ILE VAL CYS ALA ASP SEQRES 22 A 489 ALA ASP LEU ASP LEU ALA VAL GLU CYS ALA HIS GLN GLY SEQRES 23 A 489 VAL PHE PHE ASN GLN GLY GLN CYS CYS THR ALA ALA SER SEQRES 24 A 489 ARG VAL PHE VAL GLU GLU GLN VAL TYR SER GLU PHE VAL SEQRES 25 A 489 ARG ARG SER VAL GLU TYR ALA LYS LYS ARG PRO VAL GLY SEQRES 26 A 489 ASP PRO PHE ASP VAL LYS THR GLU GLN GLY PRO GLN ILE SEQRES 27 A 489 ASP GLN LYS GLN PHE ASP LYS ILE LEU GLU LEU ILE GLU SEQRES 28 A 489 SER GLY LYS LYS GLU GLY ALA LYS LEU GLU CYS GLY GLY SEQRES 29 A 489 SER ALA MET GLU ASP LYS GLY LEU PHE ILE LYS PRO THR SEQRES 30 A 489 VAL PHE SER GLU VAL THR ASP ASN MET ARG ILE ALA LYS SEQRES 31 A 489 GLU GLU ILE PHE GLY PRO VAL GLN PRO ILE LEU LYS PHE SEQRES 32 A 489 LYS SER ILE GLU GLU VAL ILE LYS ARG ALA ASN SER THR SEQRES 33 A 489 ASP TYR GLY LEU THR ALA ALA VAL PHE THR LYS ASN LEU SEQRES 34 A 489 ASP LYS ALA LEU LYS LEU ALA SER ALA LEU GLU SER GLY SEQRES 35 A 489 THR VAL TRP ILE ASN CYS TYR ASN ALA LEU TYR ALA GLN SEQRES 36 A 489 ALA PRO PHE GLY GLY PHE LYS MET SER GLY ASN GLY ARG SEQRES 37 A 489 GLU LEU GLY GLU TYR ALA LEU ALA GLU TYR THR GLU VAL SEQRES 38 A 489 LYS THR VAL THR ILE LYS LEU GLY SEQRES 1 B 489 LEU PRO ARG PRO ILE ARG ASN LEU GLU VAL LYS PHE THR SEQRES 2 B 489 LYS ILE PHE ILE ASN ASN GLU TRP HIS GLU SER LYS SER SEQRES 3 B 489 GLY LYS LYS PHE ALA THR CYS ASN PRO SER THR ARG GLU SEQRES 4 B 489 GLN ILE CYS GLU VAL GLU GLU GLY ASP LYS PRO ASP VAL SEQRES 5 B 489 ASP LYS ALA VAL GLU ALA ALA GLN VAL ALA PHE GLN ARG SEQRES 6 B 489 GLY SER PRO TRP ARG ARG LEU ASP ALA LEU SER ARG GLY SEQRES 7 B 489 ARG LEU LEU HIS GLN LEU ALA ASP LEU VAL GLU ARG ASP SEQRES 8 B 489 ARG ALA THR LEU ALA ALA LEU GLU THR MET ASP THR GLY SEQRES 9 B 489 LYS PRO PHE LEU HIS ALA PHE PHE ILE ASP LEU GLU GLY SEQRES 10 B 489 CYS ILE ARG THR LEU ARG TYR PHE ALA GLY TRP ALA ASP SEQRES 11 B 489 LYS ILE GLN GLY LYS THR ILE PRO THR ASP ASP ASN VAL SEQRES 12 B 489 VAL CYS PHE THR ARG HIS GLU PRO ILE GLY VAL CYS GLY SEQRES 13 B 489 ALA ILE THR PRO TRP ASN PHE PRO LEU LEU MET LEU VAL SEQRES 14 B 489 TRP LYS LEU ALA PRO ALA LEU CYS CYS GLY ASN THR MET SEQRES 15 B 489 VAL LEU LYS PRO ALA GLU GLN THR PRO LEU THR ALA LEU SEQRES 16 B 489 TYR LEU GLY SER LEU ILE LYS GLU ALA GLY PHE PRO PRO SEQRES 17 B 489 GLY VAL VAL ASN ILE VAL PRO GLY PHE GLY PRO THR VAL SEQRES 18 B 489 GLY ALA ALA ILE SER SER HIS PRO GLN ILE ASN LYS ILE SEQRES 19 B 489 ALA PHE THR GLY SER THR GLU VAL GLY LYS LEU VAL LYS SEQRES 20 B 489 GLU ALA ALA SER ARG SER ASN LEU LYS ARG VAL THR LEU SEQRES 21 B 489 GLU LEU GLY GLY LYS ASN PRO CYS ILE VAL CYS ALA ASP SEQRES 22 B 489 ALA ASP LEU ASP LEU ALA VAL GLU CYS ALA HIS GLN GLY SEQRES 23 B 489 VAL PHE PHE ASN GLN GLY GLN CYS CYS THR ALA ALA SER SEQRES 24 B 489 ARG VAL PHE VAL GLU GLU GLN VAL TYR SER GLU PHE VAL SEQRES 25 B 489 ARG ARG SER VAL GLU TYR ALA LYS LYS ARG PRO VAL GLY SEQRES 26 B 489 ASP PRO PHE ASP VAL LYS THR GLU GLN GLY PRO GLN ILE SEQRES 27 B 489 ASP GLN LYS GLN PHE ASP LYS ILE LEU GLU LEU ILE GLU SEQRES 28 B 489 SER GLY LYS LYS GLU GLY ALA LYS LEU GLU CYS GLY GLY SEQRES 29 B 489 SER ALA MET GLU ASP LYS GLY LEU PHE ILE LYS PRO THR SEQRES 30 B 489 VAL PHE SER GLU VAL THR ASP ASN MET ARG ILE ALA LYS SEQRES 31 B 489 GLU GLU ILE PHE GLY PRO VAL GLN PRO ILE LEU LYS PHE SEQRES 32 B 489 LYS SER ILE GLU GLU VAL ILE LYS ARG ALA ASN SER THR SEQRES 33 B 489 ASP TYR GLY LEU THR ALA ALA VAL PHE THR LYS ASN LEU SEQRES 34 B 489 ASP LYS ALA LEU LYS LEU ALA SER ALA LEU GLU SER GLY SEQRES 35 B 489 THR VAL TRP ILE ASN CYS TYR ASN ALA LEU TYR ALA GLN SEQRES 36 B 489 ALA PRO PHE GLY GLY PHE LYS MET SER GLY ASN GLY ARG SEQRES 37 B 489 GLU LEU GLY GLU TYR ALA LEU ALA GLU TYR THR GLU VAL SEQRES 38 B 489 LYS THR VAL THR ILE LYS LEU GLY HET NAD A 601 44 HET GOL A 602 14 HET KXT A 603 35 HET GOL A 604 14 HET NAD B 601 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM GOL GLYCEROL HETNAM KXT 2,6-DIPHENYLIMIDAZO[1,2-A]PYRIDINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 5 KXT C19 H14 N2 FORMUL 8 HOH *11(H2 O) HELIX 1 AA1 ASP A 67 GLN A 83 1 17 HELIX 2 AA2 ASP A 92 ASP A 110 1 19 HELIX 3 AA3 ARG A 111 GLY A 123 1 13 HELIX 4 AA4 PRO A 125 ILE A 132 1 8 HELIX 5 AA5 ILE A 132 ALA A 148 1 17 HELIX 6 AA6 ASP A 149 ILE A 151 5 3 HELIX 7 AA7 PHE A 182 CYS A 196 1 15 HELIX 8 AA8 PRO A 210 ALA A 223 1 14 HELIX 9 AA9 VAL A 240 SER A 245 1 6 HELIX 10 AB1 SER A 258 SER A 272 1 15 HELIX 11 AB2 ASP A 294 GLY A 305 1 12 HELIX 12 AB3 GLU A 324 LYS A 339 1 16 HELIX 13 AB4 ASP A 358 GLU A 375 1 18 HELIX 14 AB5 MET A 405 GLU A 410 1 6 HELIX 15 AB6 SER A 424 SER A 434 1 11 HELIX 16 AB7 ASN A 447 LEU A 458 1 12 HELIX 17 AB8 GLY A 490 THR A 498 5 9 HELIX 18 AB9 ASP B 67 GLN B 83 1 17 HELIX 19 AC1 SER B 86 LEU B 91 1 6 HELIX 20 AC2 ASP B 92 HIS B 101 1 10 HELIX 21 AC3 LEU B 103 ASP B 110 1 8 HELIX 22 AC4 ASP B 110 GLY B 123 1 14 HELIX 23 AC5 PRO B 125 ILE B 132 1 8 HELIX 24 AC6 ILE B 132 ALA B 148 1 17 HELIX 25 AC7 ASP B 149 ILE B 151 5 3 HELIX 26 AC8 PHE B 182 CYS B 197 1 16 HELIX 27 AC9 PRO B 210 ALA B 223 1 14 HELIX 28 AD1 THR B 239 HIS B 247 1 9 HELIX 29 AD2 SER B 258 ASN B 273 1 16 HELIX 30 AD3 ASP B 294 PHE B 308 1 15 HELIX 31 AD4 ASN B 309 GLN B 312 5 4 HELIX 32 AD5 GLU B 324 ARG B 341 1 18 HELIX 33 AD6 ASP B 358 GLY B 376 1 19 HELIX 34 AD7 MET B 405 GLU B 410 1 6 HELIX 35 AD8 SER B 424 ASN B 433 1 10 HELIX 36 AD9 ASN B 447 LEU B 458 1 12 HELIX 37 AE1 GLU B 491 GLU B 496 5 6 SHEET 1 AA1 2 ILE A 34 ILE A 36 0 SHEET 2 AA1 2 GLU A 39 HIS A 41 -1 O HIS A 41 N ILE A 34 SHEET 1 AA2 2 LYS A 48 CYS A 52 0 SHEET 2 AA2 2 GLN A 59 GLU A 64 -1 O VAL A 63 N PHE A 49 SHEET 1 AA310 LYS A 154 ILE A 156 0 SHEET 2 AA310 VAL A 162 GLU A 169 -1 O THR A 166 N LYS A 154 SHEET 3 AA310 GLU A 499 LYS A 506 -1 O ILE A 505 N VAL A 163 SHEET 4 AA310 THR B 462 ILE B 465 1 O VAL B 463 N THR A 502 SHEET 5 AA310 THR B 440 PHE B 444 1 N ALA B 441 O THR B 462 SHEET 6 AA310 PRO B 286 VAL B 289 1 N ILE B 288 O ALA B 442 SHEET 7 AA310 ARG B 319 GLU B 323 1 O ARG B 319 N CYS B 287 SHEET 8 AA310 VAL B 416 PHE B 422 1 O LEU B 420 N VAL B 320 SHEET 9 AA310 THR B 396 VAL B 401 1 N PHE B 398 O ILE B 419 SHEET 10 AA310 LYS B 378 CYS B 381 -1 N LYS B 378 O SER B 399 SHEET 1 AA4 6 VAL A 230 ILE A 232 0 SHEET 2 AA4 6 MET A 201 LYS A 204 1 N LEU A 203 O ASN A 231 SHEET 3 AA4 6 CYS A 174 ILE A 177 1 N ALA A 176 O LYS A 204 SHEET 4 AA4 6 LYS A 252 THR A 256 1 O LYS A 252 N GLY A 175 SHEET 5 AA4 6 ARG A 276 GLU A 280 1 O ARG A 276 N ILE A 253 SHEET 6 AA4 6 GLY A 484 ASN A 485 -1 O ASN A 485 N LEU A 279 SHEET 1 AA5 8 ILE A 419 PHE A 422 0 SHEET 2 AA5 8 VAL A 320 GLU A 323 1 N VAL A 322 O LEU A 420 SHEET 3 AA5 8 CYS A 287 VAL A 289 1 N VAL A 289 O PHE A 321 SHEET 4 AA5 8 ALA A 442 PHE A 444 1 O ALA A 442 N ILE A 288 SHEET 5 AA5 8 THR A 462 ILE A 465 1 O TRP A 464 N VAL A 443 SHEET 6 AA5 8 THR B 498 LYS B 506 1 O THR B 502 N VAL A 463 SHEET 7 AA5 8 VAL B 162 PRO B 170 -1 N VAL B 163 O ILE B 505 SHEET 8 AA5 8 LYS B 154 ILE B 156 -1 N LYS B 154 O THR B 166 SHEET 1 AA6 2 TYR A 437 GLY A 438 0 SHEET 2 AA6 2 PHE A 480 LYS A 481 -1 O PHE A 480 N GLY A 438 SHEET 1 AA7 2 PHE A 477 GLY A 478 0 SHEET 2 AA7 2 ARG A 487 GLU A 488 -1 O GLU A 488 N PHE A 477 SHEET 1 AA8 2 ILE B 34 ILE B 36 0 SHEET 2 AA8 2 GLU B 39 HIS B 41 -1 O GLU B 39 N ILE B 36 SHEET 1 AA9 2 LYS B 48 CYS B 52 0 SHEET 2 AA9 2 GLN B 59 GLU B 64 -1 O VAL B 63 N PHE B 49 SHEET 1 AB1 6 VAL B 230 ILE B 232 0 SHEET 2 AB1 6 THR B 200 LYS B 204 1 N LEU B 203 O ASN B 231 SHEET 3 AB1 6 VAL B 173 ILE B 177 1 N CYS B 174 O THR B 200 SHEET 4 AB1 6 LYS B 252 THR B 256 1 O LYS B 252 N GLY B 175 SHEET 5 AB1 6 ARG B 276 GLU B 280 1 O ARG B 276 N ILE B 253 SHEET 6 AB1 6 GLY B 484 ASN B 485 -1 O ASN B 485 N LEU B 279 SHEET 1 AB2 2 ALA B 385 MET B 386 0 SHEET 2 AB2 2 PHE B 392 ILE B 393 -1 O PHE B 392 N MET B 386 SHEET 1 AB3 2 TYR B 437 GLY B 438 0 SHEET 2 AB3 2 PHE B 480 LYS B 481 -1 O PHE B 480 N GLY B 438 SHEET 1 AB4 2 PHE B 477 GLY B 478 0 SHEET 2 AB4 2 ARG B 487 GLU B 488 -1 O GLU B 488 N PHE B 477 LINK NZ LYS A 204 O2B NAD A 601 1555 1555 1.30 LINK O3D NAD A 601 NZ LYS B 47 3555 1555 1.30 SITE 1 AC1 3 ILE A 151 THR A 155 ARG A 167 SITE 1 AC2 4 PHE A 131 GLU A 135 GLY A 136 LEU A 471 SITE 1 AC3 6 LYS A 266 VAL A 277 ASN A 485 LYS B 266 SITE 2 AC3 6 ARG B 276 VAL B 277 SITE 1 AC4 14 ILE B 177 THR B 178 TRP B 180 LYS B 204 SITE 2 AC4 14 ALA B 206 GLU B 207 GLY B 237 GLY B 241 SITE 3 AC4 14 ALA B 242 PHE B 255 SER B 258 VAL B 261 SITE 4 AC4 14 LYS B 360 LYS B 364 SITE 1 AC5 41 SER A 43 SER A 45 GLY A 46 LYS A 48 SITE 2 AC5 41 GLU A 65 ILE A 177 THR A 178 PRO A 179 SITE 3 AC5 41 TRP A 180 LYS A 204 ALA A 206 GLU A 207 SITE 4 AC5 41 GLY A 237 GLY A 241 ALA A 242 PHE A 255 SITE 5 AC5 41 SER A 258 VAL A 261 LYS A 360 GLN A 361 SITE 6 AC5 41 SER B 43 SER B 45 GLY B 46 LYS B 48 SITE 7 AC5 41 GLU B 64 GLU B 65 ASP B 72 ILE B 177 SITE 8 AC5 41 THR B 178 TRP B 180 LYS B 204 ALA B 206 SITE 9 AC5 41 GLU B 207 GLY B 237 GLY B 241 ALA B 242 SITE 10 AC5 41 PHE B 255 SER B 258 VAL B 261 LYS B 360 SITE 11 AC5 41 LYS B 364 CRYST1 81.557 89.357 159.037 90.00 90.00 90.00 P 21 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012261 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011191 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006288 0.00000